> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA OK’s Baxter’s Premix Norepinephrine
- URL: https://www.fdaweb.com/fda-oks-baxters-premix-norepinephrine/
- Published: 2021-09-23T12:00:00.000Z
- Updated: 2026-09-14T17:15:48.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5150213

FDA has approved Baxter’s premix norepinephrine bitartrate in 5% dextrose injection, indicated for raising blood pressure in adult patients with severe, acute hypotension (low blood pressure). The ready-to-use formulation and is available in 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL) strengths. The company says the formulations have a shelf life of up to 21 months in a refrigerator, or up to 90 days at room temperature.